Evolent director granted 41,096 stock units
Evolent Health, Inc. director Jill D. Smith reported an equity compensation grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Evolent Health, Inc. director Jill D. Smith reported an equity compensation grant. She acquired 41,096 shares of Class A Common Stock in the form of restricted stock units granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
The securities vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting, contingent on her continued service through the vesting date. Following this award, Smith holds 64,233 shares of Evolent Health common stock directly.
Insider Trade Summary
Grant/Award: 41,096 shares
Grant/Award
1 txn
Insider
Smith Jill D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 41,096 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 64,233 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Key Figures
RSU grant size: 41,096 shares
Shares after transaction: 64,233 shares
Vesting date: June 4, 2027
+2 more
5 metrics
RSU grant size
41,096 shares
Restricted stock units granted to director Jill D. Smith
Shares after transaction
64,233 shares
Total direct holdings following award
Vesting date
June 4, 2027
Earlier of this date or 2027 annual meeting
Transaction code
A (Grant, award, or other acquisition)
Indicates equity compensation grant, not market trade
Reported price per share
$0.00
Compensation award, no cash paid by insider
Key Terms
restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vest, Class A Common Stock
4 terms
restricted stock units financial
"Represents restricted stock units granted to Ms. Smith pursuant to the Amended"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"granted to Ms. Smith pursuant to the Amended and Restated Evolent Health, Inc."
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Class A Common Stock financial
"security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Evolent Health (EVH) disclose for Jill D. Smith?
Evolent Health director Jill D. Smith received a grant of 41,096 restricted stock units as equity compensation. These units represent Class A Common Stock and increase her direct holdings to 64,233 shares after the award.
When do Jill D. Smith’s new Evolent Health (EVH) restricted stock units vest?
The restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Jill D. Smith’s continued service with the company through the applicable vesting date.
Under which plan were Jill D. Smith’s Evolent Health (EVH) restricted stock units granted?
The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan is used by the company to deliver stock-based compensation to directors and other eligible participants.
Was Jill D. Smith’s Evolent Health (EVH) Form 4 transaction a market purchase or sale?
The transaction was not a market trade. It was reported with code “A” as a grant or award acquisition, reflecting restricted stock units granted as compensation at a reported price of $0.00 per share rather than an open-market transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
